These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 29752050)
1. Stakeholder roles in facilitating access to essential medicines. Duong MH; Moles RJ; Chaar B; Chen TF Res Social Adm Pharm; 2019 Mar; 15(3):260-266. PubMed ID: 29752050 [TBL] [Abstract][Full Text] [Related]
2. Stakeholder perspectives on the challenges surrounding management and supply of essential medicines. Duong MH; Moles RJ; Chaar B; Chen TF Int J Clin Pharm; 2019 Oct; 41(5):1210-1219. PubMed ID: 31444686 [TBL] [Abstract][Full Text] [Related]
3. Issues affecting supply of palliative medicines into community pharmacy: A qualitative study of community pharmacist and pharmaceutical wholesaler/distributor perspectives. Campling N; Breen L; Miller E; Birtwistle J; Richardson A; Bennett M; Latter S Explor Res Clin Soc Pharm; 2022 Jun; 6():100132. PubMed ID: 35909712 [TBL] [Abstract][Full Text] [Related]
4. Essential Medicines in a High Income Country: Essential to Whom? Duong M; Moles RJ; Chaar B; Chen TF; PLoS One; 2015; 10(12):e0143654. PubMed ID: 26650544 [TBL] [Abstract][Full Text] [Related]
5. How the quality of essential medicines is perceived and maintained through the pharmaceutical supply chain: A perspective from stakeholders in Nigeria. Amadi C; Tsui EK Res Social Adm Pharm; 2019 Nov; 15(11):1344-1357. PubMed ID: 30509851 [TBL] [Abstract][Full Text] [Related]
6. Access to cancer medication in public hospitals in a middle-income country: The view of stakeholder. Moye-Holz D; Dreser A; van Dijk JP; Reijneveld SA; Hogerzeil HV Res Social Adm Pharm; 2020 Sep; 16(9):1255-1263. PubMed ID: 31796333 [TBL] [Abstract][Full Text] [Related]
7. The growing role of biologics and biosimilars in the United States: Perspectives from the APhA Biologics and Biosimilars Stakeholder Conference. Crespi-Lofton J; Skelton JB J Am Pharm Assoc (2003); 2017; 57(5):e15-e27. PubMed ID: 28689708 [TBL] [Abstract][Full Text] [Related]
8. Acceptability and feasibility of a national essential medicines list in Canada: a qualitative study of perceptions of decision-makers and policy stakeholders. Jarvis JD; Murphy A; Perel P; Persaud N CMAJ; 2019 Oct; 191(40):E1093-E1099. PubMed ID: 31591095 [TBL] [Abstract][Full Text] [Related]
9. Varying viewpoints of Belgian stakeholders on models of interhospital collaboration. De Regge M; De Pourcq K; Gemmel P; Van de Voorde C; Van den Heede K; Eeckloo K BMC Health Serv Res; 2018 Dec; 18(1):942. PubMed ID: 30514304 [TBL] [Abstract][Full Text] [Related]
10. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol. Newell S; Jordan Z JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009 [TBL] [Abstract][Full Text] [Related]
11. Exploring global and country-level barriers to an effective supply of leishmaniasis medicines and diagnostics in eastern Africa: a qualitative study. Sunyoto T; Potet J; den Boer M; Ritmeijer K; Postigo JAR; Ravinetto R; Alves F; Picado A; Boelaert M BMJ Open; 2019 May; 9(5):e029141. PubMed ID: 31152044 [TBL] [Abstract][Full Text] [Related]
12. Supply chain management of health commodities for reducing global disease burden. Chukwu OA; Ezeanochikwa VN; Eya BE Res Social Adm Pharm; 2017; 13(4):871-874. PubMed ID: 27720436 [TBL] [Abstract][Full Text] [Related]
13. Impact of the COVID-19 Pandemic on Medical Product Procurement, Prices, and Supply Chain in Zimbabwe: Lessons for Supply Chain Resiliency. Yemeke TT; Umaru FA; Ferrand RA; Ozawa S Glob Health Sci Pract; 2023 Oct; 11(5):. PubMed ID: 37903588 [TBL] [Abstract][Full Text] [Related]
14. Stakeholder analysis for the development of a community pharmacy service aimed at preventing cardiovascular disease. Franco-Trigo L; Hossain LN; Durks D; Fam D; Inglis SC; Benrimoj SI; Sabater-Hernández D Res Social Adm Pharm; 2017; 13(3):539-552. PubMed ID: 27485770 [TBL] [Abstract][Full Text] [Related]
15. Analyzing implementation dynamics using theory-driven evaluation principles: lessons learnt from a South African centralized chronic dispensing model. Magadzire BP; Marchal B; Mathys T; Laing RO; Ward K BMC Health Serv Res; 2017 Dec; 17(Suppl 2):724. PubMed ID: 29219098 [TBL] [Abstract][Full Text] [Related]
16. What impact does medicines shortages have on patients? A qualitative study exploring patients' experience and views of healthcare professionals. Atif M; Sehar A; Malik I; Mushtaq I; Ahmad N; Babar ZU BMC Health Serv Res; 2021 Aug; 21(1):827. PubMed ID: 34404420 [TBL] [Abstract][Full Text] [Related]
17. National stakeholders' perceptions of the processes that inform the development of national clinical practice guidelines for primary healthcare in South Africa. Kredo T; Cooper S; Abrams A; Daniels K; Volmink J; Atkins S Health Res Policy Syst; 2018 Jul; 16(1):68. PubMed ID: 30064440 [TBL] [Abstract][Full Text] [Related]
18. Stakeholders' views of UK nurse and pharmacist supplementary prescribing. Cooper R; Anderson C; Avery T; Bissell P; Guillaume L; Hutchinson A; Lymn J; Murphy E; Ratcliffe J; Ward P J Health Serv Res Policy; 2008 Oct; 13(4):215-21. PubMed ID: 18806179 [TBL] [Abstract][Full Text] [Related]
19. Improving access to medicines via the Health Impact Fund in India: a stakeholder analysis. McMullan P; Ajay VS; Srinivas R; Bhalla S; Prabhakaran D; Banerjee A Glob Health Action; 2018; 11(1):1434935. PubMed ID: 29495950 [TBL] [Abstract][Full Text] [Related]
20. The Station Community Mental Health Centre Inc: nurturing and empowering. Taylor J; Jones RM; O'Reilly P; Oldfield W; Blackburn A Rural Remote Health; 2010; 10(3):1411. PubMed ID: 20701415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]